Abstract
To identify the fate of the allticancer drug daunomycin (DAU) in the rat the distribution of DAU and the formation of its metabolite daunomycinol (DOL) are described with first order processes in a double seven-compartment model. For DAU and DOL the compartments represent plasma; liver; spleen; well-perfused organs heart. kidneys. lungs. muscles in one “tissues.l” compartment; other tissues in a “tissues.2” compartment; and two excretion fluids. urine and bile. Anatomically determined pathways link the compartments. DAU and DOL concentrations are observed (high performance liquid chromatography (HPLC) method) in all compartments. except tissues.2. at various timepoints after a single i.v. injection of DAU. This input is modeled as an instantaneous loading of the plasma DAU compartment at time zero. Twenty-five rate constants that describe the dynamic system behaviour in terms of concentration-time histories are estimated by automatic optimization in the maximum likelihood (ML) sense. Three different optimization routines are described: 1) a modified Gauss-Newton method based on the solution of analytical sensivity differential equations (MGN); 2) a finite differences approach to the computation (FD); or 3) a direct determination of the gradient vector and the Hessian matrix of the log-likelihood function in the parameter space. again through finite differences (DEH). The performance of the three methods with respect to convergence characteristics. accuracy of results and speed of computation is compared. With proper precautions taken to prevent divergence the MGN method performs better than the DEH method. The FD approach may speed up computation only marginally. Revision of the assumption of first order kinetics seems necessary.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.